337 related articles for article (PubMed ID: 25679213)
1. Glycation of human cortical and cancellous bone captures differences in the formation of Maillard reaction products between glucose and ribose.
Sroga GE; Siddula A; Vashishth D
PLoS One; 2015; 10(2):e0117240. PubMed ID: 25679213
[TBL] [Abstract][Full Text] [Related]
2. Differences in non-enzymatic glycation and collagen cross-links between human cortical and cancellous bone.
Karim L; Tang SY; Sroga GE; Vashishth D
Osteoporos Int; 2013 Sep; 24(9):2441-7. PubMed ID: 23471564
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
[TBL] [Abstract][Full Text] [Related]
5. Assessing glycation-mediated changes in human cortical bone with Raman spectroscopy.
Unal M; Uppuganti S; Leverant CJ; Creecy A; Granke M; Voziyan P; Nyman JS
J Biophotonics; 2018 Aug; 11(8):e201700352. PubMed ID: 29575566
[TBL] [Abstract][Full Text] [Related]
6. Effects of non-enzymatic glycation on cancellous bone fragility.
Tang SY; Zeenath U; Vashishth D
Bone; 2007 Apr; 40(4):1144-51. PubMed ID: 17257914
[TBL] [Abstract][Full Text] [Related]
7. Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
Verzijl N; DeGroot J; Oldehinkel E; Bank RA; Thorpe SR; Baynes JW; Bayliss MT; Bijlsma JW; Lafeber FP; Tekoppele JM
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):381-7. PubMed ID: 10947951
[TBL] [Abstract][Full Text] [Related]
8. Ribosylation rapidly induces alpha-synuclein to form highly cytotoxic molten globules of advanced glycation end products.
Chen L; Wei Y; Wang X; He R
PLoS One; 2010 Feb; 5(2):e9052. PubMed ID: 20140223
[TBL] [Abstract][Full Text] [Related]
9. D-ribose induces cellular protein glycation and impairs mouse spatial cognition.
Han C; Lu Y; Wei Y; Liu Y; He R
PLoS One; 2011; 6(9):e24623. PubMed ID: 21966363
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor 1, glycation and bone fragility: implications for fracture resistance of bone.
Sroga GE; Wu PC; Vashishth D
PLoS One; 2015; 10(1):e0117046. PubMed ID: 25629402
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneous glycation of cancellous bone and its association with bone quality and fragility.
Karim L; Vashishth D
PLoS One; 2012; 7(4):e35047. PubMed ID: 22514706
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of carboxymethyl-lysine (CML) in human cortical bone.
Thomas CJ; Cleland TP; Sroga GE; Vashishth D
Bone; 2018 May; 110():128-133. PubMed ID: 29408699
[TBL] [Abstract][Full Text] [Related]
13. New biomarkers of Maillard reaction damage to proteins.
Wells-Knecht KJ; Brinkmann E; Wells-Knecht MC; Litchfield JE; Ahmed MU; Reddy S; Zyzak DV; Thorpe SR; Baynes JW
Nephrol Dial Transplant; 1996; 11 Suppl 5():41-7. PubMed ID: 9044306
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive skin autofluorescence, blood and urine assays of the advanced glycation end product (AGE) pentosidine as an indirect indicator of AGE content in human bone.
Kida Y; Saito M; Shinohara A; Soshi S; Marumo K
BMC Musculoskelet Disord; 2019 Dec; 20(1):627. PubMed ID: 31881872
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors.
Grandhee SK; Monnier VM
J Biol Chem; 1991 Jun; 266(18):11649-53. PubMed ID: 1904866
[TBL] [Abstract][Full Text] [Related]
16. Ratio of Endogenous Secretory Receptor for Advanced Glycation End Products to Pentosidine Predicts Fractures in Men.
Tamaki J; Kouda K; Fujita Y; Iki M; Yura A; Miura M; Sato Y; Okamoto N; Kurumatani N
J Clin Endocrinol Metab; 2018 Jan; 103(1):85-94. PubMed ID: 29040721
[TBL] [Abstract][Full Text] [Related]
17. Creatine plays a direct role as a protein modifier in the formation of a novel advanced glycation end product.
Miyazaki K; Nagai R; Horiuchi S
J Biochem; 2002 Oct; 132(4):543-50. PubMed ID: 12359068
[TBL] [Abstract][Full Text] [Related]
18. Association between non-enzymatic glycation, resorption, and microdamage in human tibial cortices.
Ural A; Janeiro C; Karim L; Diab T; Vashishth D
Osteoporos Int; 2015 Mar; 26(3):865-873. PubMed ID: 25326375
[TBL] [Abstract][Full Text] [Related]
19. Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products.
DeGroot J; Verzijl N; Wenting-Van Wijk MJ; Bank RA; Lafeber FP; Bijlsma JW; TeKoppele JM
Arthritis Rheum; 2001 Nov; 44(11):2562-71. PubMed ID: 11710713
[TBL] [Abstract][Full Text] [Related]
20. d-Ribose contributes to the glycation of serum protein.
Chen Y; Yu L; Wang Y; Wei Y; Xu Y; He T; He R
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2285-2292. PubMed ID: 31085227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
